Literature DB >> 8391179

Neoplastic transformation of immortalized human epidermal keratinocytes by two HHV-6 DNA clones.

A Razzaque1, O Williams, J Wang, J S Rhim.   

Abstract

Human herpesvirus-6 (HHV-6) DNA and high antibody titers have been detected in some human malignancies. To understand the role of HHV-6 in human cancer, the ability of these DNA sequences to convert nontumorigenic human epidermal keratinocytes (RHEK-1) to the tumorigenic phenotype was examined. Of the three HHV-6 clones tested, pZVH14 (8.7-kb insert) and pZVB70 (21-kb insert) exhibited transforming activity in RHEK-1 cells, whereas the other clone pZVE50 (6-kb insert) did not show any activity. Transformed cells were morphologically altered, forming bundles or islets, and produced tumors when injected into nude mice. Southern blot analysis of the pZVH14 DNA-transformed and tumor cells revealed multiple bands hybridizing to the 8.7-kb DNA insert of pZVH14. Karyotype analysis identified the mouse tumor cells to be of human origin and these cells exhibited some chromosomal aberration compared to untransfected RHEK-1 cells. This study demonstrates that pZVH14 DNA detected in some human tumors, and pZVB70 DNA can transform human cells in vitro to tumorigenic phenotype. These data are consistent with the possibility that HHV-6 DNA sequences may have some role in the development of some human cancers.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8391179     DOI: 10.1006/viro.1993.1351

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  11 in total

Review 1.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Association of human beta-herpesviruses with the development of cervical cancer: bystanders or cofactors.

Authors:  P K Chan; M Y Chan; W W Li; D P Chan; J L Cheung; A F Cheng
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

3.  Expression of human herpesvirus-6 antigens in benign and malignant lymphoproliferative diseases.

Authors:  M Luppi; P Barozzi; R Garber; A Maiorana; G Bonacorsi; T Artusi; R Trovato; R Marasca; G Torelli
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

Review 4.  Human herpesviruses 6, 7, and 8 from a dermatologic perspective.

Authors:  Michael M Wolz; Gabriel F Sciallis; Mark R Pittelkow
Journal:  Mayo Clin Proc       Date:  2012-07-21       Impact factor: 7.616

5.  Identification and characterization of a human herpesvirus 6 gene segment capable of transactivating the human immunodeficiency virus type 1 long terminal repeat in an Sp1 binding site-dependent manner.

Authors:  J Wang; C Jones; M Norcross; E Bohnlein; A Razzaque
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

Review 6.  Human herpesvirus-8: detection of novel herpesvirus-like DNA sequences in Kaposi's sarcoma and other lesions.

Authors:  O M Memar; P L Rady; S K Tyring
Journal:  J Mol Med (Berl)       Date:  1995-12       Impact factor: 4.599

Review 7.  Human papillomavirus and cervical cancer.

Authors:  Eileen M Burd
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

Review 8.  Human herpesvirus 6 (HHV6) infection.

Authors:  Nahed M Abdel-Haq; Basim I Asmar
Journal:  Indian J Pediatr       Date:  2004-01       Impact factor: 5.319

9.  β-HHVs and HHV-8 in Lymphoproliferative Disorders.

Authors:  C Quadrelli; P Barozzi; G Riva; D Vallerini; E Zanetti; L Potenza; F Forghieri; M Luppi
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-10-24       Impact factor: 2.576

10.  EBV, HCMV, HHV6, and HHV7 screening in bone marrow samples from children with acute lymphoblastic leukemia.

Authors:  A Morales-Sánchez; E N Pompa-Mera; A Fajardo-Gutiérrez; F J Alvarez-Rodríguez; V C Bekker-Méndez; J de Diego Flores-Chapa; J Flores-Lujano; E Jiménez-Hernández; J G Peñaloza-González; M C Rodríguez-Zepeda; J R Torres-Nava; M M Velázquez-Aviña; R Amador-Sánchez; M Alvarado-Ibarra; N Reyes-Zepeda; R M Espinosa-Elizondo; M L Pérez-Saldivar; J C Núñez-Enríquez; J M Mejía-Aranguré; E M Fuentes-Pananá
Journal:  Biomed Res Int       Date:  2014-09-18       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.